JAK2 and acquired polycythemia vera: Although these targeted methods can provide rapid and reliable results, they are limited in their capacities to concomitantly identify additional mutations that might influence diagnosis and prognosis in both JAK2-positive PV and the rare JAK2-negative patients [5].